Ron Mayron is Director at Entera Bio Ltd. (ENTX). They have made 1 open-market trade across 1 company since 2022, most recently 2026-11-02.
CIK 0001722033
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $20K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENTX | BUY | 2022-01-18 | 2022-01-19 | $2.80 | $20K | -11.9% | -19.6% | +13.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.